Best in Biotech 2 May 2024
Eight monoclonal antibody biotechs making strides in the clinic
…is a monoclonal antibody that works by binding to TIGIT, which could activate the immune system to attack cancer cells. Typically, a fragment crystallizable (Fc) region in a monoclonal antibody,…